Therapeutic Decision-Making: A Model for Formulary Evaluation
- 1 July 1986
- journal article
- research article
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 20 (7-8) , 581-583
- https://doi.org/10.1177/106002808602000715
Abstract
A systematic approach of evaluating medications for a hospital formulary is discussed. The hospital formulary is a program of objective evaluation, selection, and use of medicinal agents in the hospital. In light of the ever-increasing numbers of new and/or improved therapeutic agents, formulary decisions must be made with an eye to the future. Therefore, it appears that the best means of choosing a medication for formulary addition, both clinically and economically, is to choose an agent based on its clinical indication(s). Examples of such indications are presented. Selecting formulary agents by indication rather than by simple drug cost or pharmacologic class should ensure the most effective utilization of therapeutic agents and hopefully a diminution of overall costs.Keywords
This publication has 6 references indexed in Scilit:
- Piperacillin Sodium: Antibacterial Spectrum, Pharmacokinetics, Clinical Efficacy, and Adverse ReactionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- Azlocillin, Mezlocillin, and Piperacillin: New Broad-Spectrum PenicillinsAnnals of Internal Medicine, 1982
- Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: A Comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinThe American Journal of Medicine, 1982
- Infection in the Compromised HostHospital Practice, 1981
- Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancerThe American Journal of Medicine, 1979
- Polymicrobial Etiology of Acute Pelvic Inflammatory DiseaseNew England Journal of Medicine, 1975